Literature DB >> 15813703

The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

Zenda L Woodman1, Sylva L U Schwager, Pierre Redelinghuys, Adriana K Carmona, Mario R W Ehlers, Edward D Sturrock.   

Abstract

sACE (somatic angiotensin-converting enzyme) consists of two homologous, N and C domains, whereas the testis isoenzyme [tACE (testis ACE)] consists of a single C domain. Both isoenzymes are shed from the cell surface by a sheddase activity, although sACE is shed much less efficiently than tACE. We hypothesize that the N domain of sACE plays a regulatory role, by occluding a recognition motif on the C domain required for ectodomain shedding and by influencing the catalytic efficiency. To test this, we constructed two mutants: CNdom-ACE and CCdom-ACE. CNdom-ACE was shed less efficiently than sACE, whereas CCdom-ACE was shed as efficiently as tACE. Notably, cleavage occurred both within the stalk and the interdomain bridge in both mutants, suggesting that a sheddase recognition motif resides within the C domain and is capable of directly cleaving at both positions. Analysis of the catalytic properties of the mutants and comparison with sACE and tACE revealed that the k(cat) for sACE and CNdom-ACE was less than or equal to the sum of the kcat values for tACE and the N-domain, suggesting negative co-operativity, whereas the kcat value for the CCdom-ACE suggested positive co-operativity between the two domains. Taken together, the results provide support for (i) the existence of a sheddase recognition motif in the C domain and (ii) molecular flexibility of the N and C domains in sACE, resulting in occlusion of the C-domain recognition motif by the N domain as well as close contact of the two domains during hydrolysis of peptide substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813703      PMCID: PMC1180724          DOI: 10.1042/BJ20050187

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.

Authors:  Z L Woodman; S Y Oppong; S Cook; N M Hooper; S L Schwager; W F Brandt; M R Ehlers; E D Sturrock
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

2.  The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5.

Authors:  Hinrich P Hansen; Andreas Recke; Ulrich Reineke; Bastian Von Tresckow; Peter Borchmann; Elke Pogge Von Strandmann; Hans Lange; Hilmar Lemke; Andreas Engert
Journal:  FASEB J       Date:  2004-03-19       Impact factor: 5.191

3.  Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies.

Authors:  Irina V Balyasnikova; Zenda L Woodman; Ronald F Albrecht; Ramanathan Natesh; K Ravi Acharya; Edward D Sturrock; Sergei M Danilov
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

4.  Regulation of membrane metalloproteolytic cleavage of L-selectin (CD62l) by the epidermal growth factor domain.

Authors:  L Zhao ; M Shey; M Farnsworth; M O Dailey
Journal:  J Biol Chem       Date:  2001-05-24       Impact factor: 5.157

5.  Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.

Authors:  Peter V Binevski; Elena A Sizova; Vladimir F Pozdnev; Olga A Kost
Journal:  FEBS Lett       Date:  2003-08-28       Impact factor: 4.124

6.  Temperature-induced selective death of the C-domain within angiotensin-converting enzyme molecule.

Authors:  Sergei Voronov; Natalia Zueva; Victor Orlov; Alexander Arutyunyan; Olga Kost
Journal:  FEBS Lett       Date:  2002-07-03       Impact factor: 4.124

7.  Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.

Authors:  Gillian I Rice; Daniel A Thomas; Peter J Grant; Anthony J Turner; Nigel M Hooper
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 8.  Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity.

Authors:  Roy A Black; John R Doedens; Rajeev Mahimkar; Richard Johnson; Lin Guo; Alison Wallace; Duke Virca; June Eisenman; Jennifer Slack; Beverly Castner; Susan W Sunnarborg; David C Lee; Rebecca Cowling; Guixian Jin; Keith Charrier; Jacques J Peschon; Ray Paxton
Journal:  Biochem Soc Symp       Date:  2003

9.  Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.

Authors:  Dimitris Georgiadis; Fabrice Beau; Bertrand Czarny; Joël Cotton; Athanasios Yiotakis; Vincent Dive
Journal:  Circ Res       Date:  2003-06-12       Impact factor: 17.367

Review 10.  Ace revisited: a new target for structure-based drug design.

Authors:  K Ravi Acharya; Edward D Sturrock; James F Riordan; Mario R W Ehlers
Journal:  Nat Rev Drug Discov       Date:  2003-11       Impact factor: 84.694

View more
  10 in total

Review 1.  Interacting cogs in the machinery of the renin angiotensin system.

Authors:  Lizelle Lubbe; Edward D Sturrock
Journal:  Biophys Rev       Date:  2019-06-08

2.  Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.

Authors:  Jeff C Joyner; Lalintip Hocharoen; J A Cowan
Journal:  J Am Chem Soc       Date:  2012-02-10       Impact factor: 15.419

3.  Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.

Authors:  Olga E Skirgello; Peter V Binevski; Vladimir F Pozdnev; Olga A Kost
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 4.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

5.  QM/MM investigation of the catalytic mechanism of angiotensin-converting enzyme.

Authors:  Xia Mu; Chunchun Zhang; Dingguo Xu
Journal:  J Mol Model       Date:  2016-05-16       Impact factor: 1.810

6.  A small region in the angiotensin-converting enzyme distal ectodomain is required for cleavage-secretion of the protein at the plasma membrane.

Authors:  Saurabh Chattopadhyay; Goutam Karan; Indira Sen; Ganes C Sen
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

7.  The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae.

Authors:  Susan Burnham; Judith A Smith; Alison J Lee; R Elwyn Isaac; Alan D Shirras
Journal:  BMC Genomics       Date:  2005-12-05       Impact factor: 3.969

Review 8.  Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme.

Authors:  Romer A Gonzalez-Villalobos; Xiao Z Shen; Ellen A Bernstein; Tea Janjulia; Brian Taylor; Jorge F Giani; Wendell-Lamar B Blackwell; Kandarp H Shah; Peng D Shi; Sebastien Fuchs; Kenneth E Bernstein
Journal:  J Mol Med (Berl)       Date:  2013-05-18       Impact factor: 5.606

9.  Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Ross G Douglas; Edward D Sturrock; K Ravi Acharya
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

10.  Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.

Authors:  Kate M Larmuth; Geoffrey Masuyer; Ross G Douglas; Sylva L Schwager; K Ravi Acharya; Edward D Sturrock
Journal:  FEBS J       Date:  2016-02-09       Impact factor: 5.542

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.